Home > Insider Trading > Glaxosmithkline Plc

Glaxosmithkline Plc (GSK)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
151 - 160
Next >>

GlaxoSmithKline PLC (ADR) (GSK) Targeting Blockbuster Sales With Shingles Vaccine On EU Approval

GlaxoSmithKline plc (ADR) (NYSE:GSK) has moved to expand the target market for its blockbuster vaccine, Shingrix, with the filing of a regulatory application in Europe.

Keep Reading →

November 30th, 2016 - News Stock Analysis

Here's Our Take On Theravance Biopharma Inc (TBPH) And GlaxoSmithKline PLC (ADR) (GSK)'s Latest Submission

Theravance Biopharma Inc (NASDAQ:TBPH) just put out an announcement relating to its closed triple asset, and the company is trading flat-to-down despite the seemingly positive development.

Keep Reading →

November 22nd, 2016 - News Stock Analysis

New Phase IV Data On VBI Vaccines, Inc. (VBIV) HBV Vaccine Show It Can Carve Out A Market From GlaxoSmithKline PLC (ADR) (GSK)

No stock is ever a sure thing, but that doesn’t mean you can’t get asymptotically close to one. Following the announcement by VBI Vaccines, Inc.

Keep Reading →

November 14th, 2016 - News Stock Analysis

US FDA Clears Propeller Integration With GlaxoSmithKline PLC (ADR) (GSK)'s Ellipta

The US Food and Drug Administration (FDA) has recently cleared the Propeller platform of Propeller Health for use with GlaxoSmithKline Plc (ADR) (NYSE:GSK)'s Ellipta dry powder inhaler (DPI), fulfilling...

Keep Reading →

November 8th, 2016 - News Stock Analysis

5 Healthcare Stocks Kahn Brothers Is Bullish On

Kahn Brothers is a New York-based hedge fund which was founded by famous American businessman Irving Kahn (who recently passed away at the age of 109 as the Oldest Money Manager) in 1978.

Keep Reading →

November 8th, 2016 - Hedge Fund Analysis Hedge Funds News

GlaxoSmithKline PLC (ADR) (GSK) Teams Up With Fimbrion Therapeutics, Inc.

GlaxoSmithKline plc (ADR) (NYSE:GSK) (GSK) has recently entered into a collaborative agreement with Fimbrion Therapeutics, Inc.

Keep Reading →

October 26th, 2016 - News Stock Analysis

GlaxoSmithKline Plc (GSK) Shrugs Skeptics Concerns To Launch Cold Flu Tracker App

GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its unveiling.

Keep Reading →

October 19th, 2016 - News Stock Analysis

Medecins Sans Frontieres Happy with GlaxoSmithKline PLC (ADR) (GSK) Price Reduction For Synflorix

Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit.

Keep Reading →

September 20th, 2016 - News Stock Analysis

Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK)

Back on May 12, 2015, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee released a briefing document detailing the process for licensure of Ebola vaccines...

Keep Reading →

August 29th, 2016 - News Stock Analysis

Why Are These Five Stocks on Investors' Radars Today?

Markets are struggling to find a direction on Monday amid the Institute for Supply Management data that showed that its index of national factory activity amounted to 52.6 in June, missing the consensus...

Keep Reading →

August 1st, 2016 - Earnings Report News Tech